11/07/2024 | Press release | Distributed by Public on 11/07/2024 05:20
Three Months Ended September 30,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
(dollars in thousands, except EPS)
|
||||||||||||||||
Revenue
|
$
|
203,976
|
$
|
168,569
|
$
|
203,976
|
$
|
168,569
|
||||||||
Gross margin
|
51.4
|
%
|
52.5
|
%
|
51.6
|
%
|
52.9
|
%
|
||||||||
Income from operations
|
$
|
44,184
|
$
|
33,173
|
$
|
56,065
|
$
|
43,754
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
30,904
|
$
|
25,679
|
$
|
42,372
|
$
|
37,579
|
||||||||
Basic EPS
|
$
|
0.49
|
$
|
0.43
|
$
|
0.68
|
$
|
0.62
|
||||||||
Diluted EPS
|
$
|
0.45
|
$
|
0.39
|
$
|
0.63
|
$
|
0.57
|
Nine Months Ended September 30,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
(dollars in thousands, except EPS)
|
||||||||||||||||
Revenue
|
$
|
558,647
|
$
|
387,402
|
$
|
558,647
|
$
|
387,402
|
||||||||
Gross margin
|
50.3
|
%
|
50.9
|
%
|
50.6
|
%
|
51.1
|
%
|
||||||||
Income from operations
|
$
|
107,009
|
$
|
72,465
|
$
|
147,801
|
$
|
87,131
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
72,547
|
$
|
59,649
|
$
|
114,490
|
$
|
78,743
|
||||||||
Basic EPS
|
$
|
1.17
|
$
|
0.99
|
$
|
1.85
|
$
|
1.31
|
||||||||
Diluted EPS
|
$
|
1.07
|
$
|
0.90
|
$
|
1.70
|
$
|
1.19
|
(1) |
Reconciliations to U.S. generally accepted accounting principles ("GAAP") financial measures from non-GAAP financial measures are presented below under "Reconciliation of GAAP to Non-GAAP Financial Measures." Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized gain (loss) on short-term investments.
|
• |
Shipments. Total shipments in the third quarter of 2024 were $261 million, up 23% from the third quarter of 2023. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for potential revenue in future quarters.
|
• |
Major Performance Breakthrough for Flagship Ultra C Tahoe Cleaning Tool. The upgraded Ultra C Tahoe now achieves the performance of standalone single-wafer cleaning tools on low-to-medium temperature sulfuric peroxide mix (SPM) processes. The hybrid architecture delivers enhanced cleaning performance, high throughput, and process flexibility, with an up to 75% reduction in chemical consumption. The upgraded Ultra C Tahoe is now in production at several high-volume customer facilities in mainland China. Additional logic and memory customers are evaluating the tool, and we expect to deliver additional units through the end 2024.
|
•
|
Launched Ultra C bev-p Panel Bevel Etching Tool for Panel-Level Packaging Applications. The new tool is specifically designed for bevel etching and cleaning in copper-related processes and is capable of handling both the front and back side etching within a single system. This capability enhances process efficiency and product reliability.
|
• |
Received Orders for Wafer-Level Packaging Tools from U.S. Customer and R&D Center. ACM has received purchase orders for four wafer-level packaging tools, including two from a U.S.-based customer and two from a U.S.-based research and development (R&D) center. The four tools support a range of advanced packaging processes and are scheduled for delivery in the first half of 2025.
|
•
|
Completed Purchase of Commercial Facility in Oregon. On October 1, 2024, ACM completed the purchase of a 39,500 square foot facility, including a 5,200 square foot functional clean room. This facility is intended to augment ACM's current Oregon facility and further expand ACM's R&D and demonstration capability in the U.S. market.
|
•
|
Opening of R&D and Production Facility. On October 20, 2024, ACM Shanghai celebrated the official opening of its new R&D and production facility in Lingang, China.
|
• |
Revenue was $204.0 million, up 21%, reflecting higher sales of single wafer cleaning, Tahoe and semi-critical cleaning equipment and ECP (front-end and packaging), furnace and other technologies, partly offset by lower sales of advanced packaging (excluding ECP), services & spares.
|
• |
Gross margin was 51.4% versus 52.5%. Non-GAAP gross margin, which excludes stock-based compensation, was 51.6% versus 52.9%. Gross margin exceeded ACM's long-term business model range of 40% to 45%. ACM expects gross margin to vary from period to period due to a variety of factors, such as product mix, currency impacts and sales volume.
|
• |
Operating expenses were $60.7 million, an increase of 10%. Operating expenses as a percentage of revenue decreased to 29.7% from 32.8%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $49.2 million, up 8.5%. Non-GAAP operating expenses as a percentage of revenue decreased to 24.1% from 26.9%.
|
• |
Operating income was $44.2 million, compared to $33.2 million. Operating margin was 21.7% compared to 19.7%. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $56.1 million, compared to $43.8 million. Non-GAAP operating margin, which excludes stock-based compensation, was 27.5% compared to 26.0%.
|
• |
Unrealized gain (loss) on short-term investments was $0.4 million, compared to an unrealized gain (loss) of $(1.3) million. Unrealized gain (loss) reflects the change in market value of the investments by ACM's principal operating subsidiary, ACM Research (Shanghai), Inc. The value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.
|
• |
Income tax expense was $4.0 million, compared to $0.7 million.
|
• |
Net income attributable to ACM Research, Inc. was $30.9 million, compared to $25.7 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized gain (loss) on short-term investments, was $42.4 million, compared to $37.6 million.
|
• |
Net income per diluted share attributable to ACM Research, Inc. was $0.45, compared to $0.39. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized gain (loss) on short-term investments, was $0.63, compared to $0.57.
|
• |
Cash and cash equivalents, plus restricted cash and short-term and long-term time deposits were $369.1 million at September 30, 2024, compared to $366.8 million at June 30, 2024.
|
In the United States:
|
The Blueshirt Group
|
|
Steven C. Pelayo, CFA
|
||
(360)808-5154
|
||
In China:
|
The Blueshirt Group Asia
|
|
Gary Dvorchak, CFA
|
||
+86 (138) 1079-1480
|
||
September 30, 2024
|
December 31, 2023
|
|||||||
(Unaudited)
|
||||||||
(In thousands)
|
||||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
333,472
|
$
|
182,090
|
||||
Restricted cash
|
1,782
|
1,083
|
||||||
Short-term time deposits
|
20,304
|
80,524
|
||||||
Short-term investment
|
20,351
|
21,312
|
||||||
Accounts receivable, net
|
370,589
|
283,186
|
||||||
Other receivables
|
57,849
|
40,065
|
||||||
Inventories, net
|
628,720
|
545,395
|
||||||
Advances to related party
|
1,453
|
2,432
|
||||||
Prepaid expenses
|
10,794
|
20,023
|
||||||
Total current assets
|
1,445,314
|
1,176,110
|
||||||
Property, plant and equipment, net
|
250,099
|
201,848
|
||||||
Land use right, net
|
8,320
|
8,367
|
||||||
Operating lease right-of-use assets, net
|
5,680
|
7,026
|
||||||
Intangible assets, net
|
2,838
|
2,538
|
||||||
Long-term time deposits
|
13,517
|
40,818
|
||||||
Deferred tax assets
|
13,400
|
20,271
|
||||||
Long-term investments
|
33,655
|
27,880
|
||||||
Other long-term assets
|
21,352
|
6,050
|
||||||
Total assets
|
$
|
1,794,175
|
$
|
1,490,908
|
||||
Liabilities and Equity
|
||||||||
Current liabilities:
|
||||||||
Short-term borrowings
|
$
|
33,795
|
$
|
31,335
|
||||
Current portion of long-term borrowings
|
30,670
|
6,783
|
||||||
Related party accounts payable
|
15,392
|
11,407
|
||||||
Accounts payable
|
170,810
|
141,814
|
||||||
Advances from customers
|
215,678
|
181,368
|
||||||
Deferred revenue
|
10,138
|
3,687
|
||||||
Income taxes payable
|
6,796
|
6,401
|
||||||
FIN-48 payable
|
8,991
|
12,149
|
||||||
Other payables and accrued expenses
|
115,388
|
102,951
|
||||||
Current portion of operating lease liability
|
2,377
|
2,764
|
||||||
Total current liabilities
|
610,035
|
500,659
|
||||||
Long-term borrowings
|
106,069
|
53,952
|
||||||
Long-term operating lease liability
|
3,303
|
4,262
|
||||||
Other long-term liabilities
|
5,685
|
5,873
|
||||||
Total liabilities
|
725,092
|
564,746
|
||||||
Commitments and contingencies
|
||||||||
Equity:
|
||||||||
Stockholders' equity:
|
||||||||
Class A Common stock
|
6
|
6
|
||||||
Class B Common stock
|
1
|
1
|
||||||
Additional paid-in capital
|
669,540
|
629,845
|
||||||
Retained earnings
|
229,374
|
156,827
|
||||||
Statutory surplus reserve
|
30,060
|
30,060
|
||||||
Accumulated other comprehensive loss
|
(40,815
|
)
|
(49,349
|
)
|
||||
Total ACM Research, Inc. stockholders' equity
|
888,166
|
767,390
|
||||||
Non-controlling interests
|
180,917
|
158,772
|
||||||
Total equity
|
1,069,083
|
926,162
|
||||||
Total liabilities and equity
|
$
|
1,794,175
|
$
|
1,490,908
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
(Unaudited)
|
||||||||||||||||
( In thousands, except share and per share data)
|
||||||||||||||||
Revenue
|
$
|
203,976
|
$
|
168,569
|
$
|
558,647
|
$
|
387,402
|
||||||||
Cost of revenue
|
99,142
|
80,055
|
277,908
|
190,263
|
||||||||||||
Gross profit
|
104,834
|
88,514
|
280,739
|
197,139
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Sales and marketing
|
15,759
|
16,803
|
47,067
|
37,579
|
||||||||||||
Research and development
|
27,837
|
26,151
|
77,723
|
60,244
|
||||||||||||
General and administrative
|
17,054
|
12,387
|
48,940
|
26,851
|
||||||||||||
Total operating expenses
|
60,650
|
55,341
|
173,730
|
124,674
|
||||||||||||
Income from operations
|
44,184
|
33,173
|
107,009
|
72,465
|
||||||||||||
Interest income
|
2,967
|
2,152
|
7,122
|
6,283
|
||||||||||||
Interest expense
|
(1,208
|
)
|
(640
|
)
|
(2,923
|
)
|
(1,984
|
)
|
||||||||
Realized gain from sale of short-term investments
|
171
|
656
|
444
|
8,569
|
||||||||||||
Unrealized gain (loss) on short-term investments
|
413
|
(1,319
|
)
|
(1,151
|
)
|
(4,428
|
)
|
|||||||||
Other income (expense), net
|
(5,164
|
)
|
(2,150
|
)
|
(727
|
)
|
156
|
|||||||||
Income (loss) from equity method investments
|
1,316
|
(160
|
)
|
101
|
3,728
|
|||||||||||
Income before income taxes
|
42,679
|
31,712
|
109,875
|
84,789
|
||||||||||||
Income tax expense
|
(4,007
|
)
|
(718
|
)
|
(17,712
|
)
|
(11,235
|
)
|
||||||||
Net income
|
38,672
|
30,994
|
92,163
|
73,554
|
||||||||||||
Less: Net income attributable to non-controlling interests
|
7,768
|
5,315
|
19,616
|
13,905
|
||||||||||||
Net income attributable to ACM Research, Inc.
|
$
|
30,904
|
$
|
25,679
|
$
|
72,547
|
$
|
59,649
|
||||||||
Comprehensive income (loss):
|
||||||||||||||||
Net income
|
38,672
|
30,994
|
92,163
|
73,554
|
||||||||||||
Foreign currency translation adjustment, net of tax
|
17,089
|
4,015
|
10,376
|
(21,831
|
)
|
|||||||||||
Comprehensive Income
|
55,761
|
35,009
|
102,539
|
51,723
|
||||||||||||
Less: Comprehensive income attributable to non-controlling interests
|
10,842
|
7,768
|
21,458
|
11,882
|
||||||||||||
Comprehensive income (loss) attributable to ACM Research, Inc.
|
$
|
44,919
|
$
|
27,241
|
$
|
81,081
|
$
|
39,841
|
||||||||
Net income attributable to ACM Research, Inc. per common share:
|
||||||||||||||||
Basic
|
$
|
0.49
|
$
|
0.43
|
$
|
1.17
|
$
|
0.99
|
||||||||
Diluted
|
$
|
0.45
|
$
|
0.39
|
$
|
1.07
|
$
|
0.90
|
||||||||
Weighted average common shares outstanding used in computing per share amounts:
|
||||||||||||||||
Basic
|
62,500,903
|
60,219,218
|
62,017,257
|
59,953,144
|
||||||||||||
Diluted
|
66,671,526
|
65,450,941
|
66,512,143
|
64,834,051
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
(Unaudited)
|
||||||||||||||||
($ in thousand)
|
||||||||||||||||
Single wafer cleaning, Tahoe and semi-critical cleaning equipment
|
$
|
160,985
|
$
|
132,417
|
$
|
423,676
|
$
|
281,559
|
||||||||
ECP (front-end and packaging), furnace and other technologies
|
34,600
|
25,508
|
99,362
|
71,223
|
||||||||||||
Advanced packaging (excluding ECP), services & spares
|
8,391
|
10,644
|
35,609
|
34,620
|
||||||||||||
Total Revenue By Product Category
|
$
|
203,976
|
$
|
168,569
|
$
|
558,647
|
$
|
387,402
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
Mainland China
|
$
|
203,672
|
$
|
168,302
|
$
|
552,642
|
$
|
375,528
|
||||||||
Other Regions
|
304
|
267
|
6,005
|
11,874
|
||||||||||||
Total Revenue By Region
|
$
|
203,976
|
$
|
168,569
|
$
|
558,647
|
$
|
387,402
|
Three Months Ended September 30,
|
||||||||||||||||||||||||||||||||
2024
|
2023
|
|||||||||||||||||||||||||||||||
Actual
(GAAP)
|
SBC
|
Other non-
operating adjustments
|
Adjusted
(Non-GAAP)
|
Actual
(GAAP)
|
SBC
|
Other non-
operating adjustments
|
Adjusted
(Non-GAAP)
|
|||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
203,976
|
$
|
-
|
$
|
-
|
$
|
203,976
|
$
|
168,569
|
$
|
-
|
$
|
-
|
$
|
168,569
|
||||||||||||||||
Cost of revenue
|
(99,142
|
)
|
(447
|
)
|
-
|
(98,695
|
)
|
(80,055
|
)
|
(588
|
)
|
-
|
(79,467
|
)
|
||||||||||||||||||
Gross profit
|
104,834
|
(447
|
)
|
-
|
105,281
|
88,514
|
(588
|
)
|
-
|
89,102
|
||||||||||||||||||||||
Gross margin
|
51.4
|
%
|
0.2
|
%
|
-
|
51.6
|
%
|
52.5
|
%
|
0.3
|
%
|
-
|
52.9
|
%
|
||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(15,759
|
)
|
(2,594
|
)
|
-
|
(13,165
|
)
|
(16,803
|
)
|
(2,543
|
)
|
-
|
(14,260
|
)
|
||||||||||||||||||
Research and development
|
(27,837
|
)
|
(3,373
|
)
|
-
|
(24,464
|
)
|
(26,151
|
)
|
(3,421
|
)
|
-
|
(22,730
|
)
|
||||||||||||||||||
General and administrative
|
(17,054
|
)
|
(5,467
|
)
|
-
|
(11,587
|
)
|
(12,387
|
)
|
(4,029
|
)
|
-
|
(8,358
|
)
|
||||||||||||||||||
Total operating expenses
|
(60,650
|
)
|
(11,434
|
)
|
-
|
(49,216
|
)
|
(55,341
|
)
|
(9,993
|
)
|
-
|
(45,348
|
)
|
||||||||||||||||||
Income (loss) from operations
|
$
|
44,184
|
$
|
(11,881
|
)
|
$
|
-
|
$
|
56,065
|
$
|
33,173
|
$
|
(10,581
|
)
|
$
|
-
|
$
|
43,754
|
||||||||||||||
Unrealized gain (loss) on short-term investments
|
413
|
-
|
413
|
-
|
(1,319
|
)
|
-
|
(1,319
|
)
|
-
|
||||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
30,904
|
$
|
(11,881
|
)
|
$
|
413
|
$
|
42,372
|
$
|
25,679
|
$
|
(10,581
|
)
|
$
|
(1,319
|
)
|
$
|
37,579
|
|||||||||||||
Basic EPS
|
$
|
0.49
|
$
|
0.68
|
$
|
0.43
|
$
|
0.62
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
0.45
|
$
|
0.63
|
$
|
0.39
|
$
|
0.57
|
Nine Months Ended September 30,
|
||||||||||||||||||||||||||||||||
2024
|
2023
|
|||||||||||||||||||||||||||||||
Actual
(GAAP)
|
SBC
|
Other non-
operating adjustments
|
Adjusted
(Non-GAAP)
|
Actual
(GAAP)
|
SBC
|
Other non-
operating adjustments
|
Adjusted
(Non-GAAP)
|
|||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
558,647
|
$
|
-
|
$
|
-
|
$
|
558,647
|
$
|
387,402
|
$
|
-
|
$
|
-
|
$
|
387,402
|
||||||||||||||||
Cost of revenue
|
(277,908
|
)
|
(2,020
|
)
|
-
|
(275,888
|
)
|
(190,263
|
)
|
(838
|
)
|
-
|
(189,425
|
)
|
||||||||||||||||||
Gross profit
|
280,739
|
(2,020
|
)
|
-
|
282,759
|
197,139
|
(838
|
)
|
-
|
197,977
|
||||||||||||||||||||||
Gross margin
|
50.3
|
%
|
0.4
|
%
|
-
|
50.6
|
%
|
50.9
|
%
|
0.2
|
%
|
-
|
51.1
|
%
|
||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(47,067
|
)
|
(8,645
|
)
|
-
|
(38,422
|
)
|
(37,579
|
)
|
(3,405
|
)
|
-
|
(34,174
|
)
|
||||||||||||||||||
Research and development
|
(77,723
|
)
|
(12,082
|
)
|
-
|
(65,641
|
)
|
(60,244
|
)
|
(4,831
|
)
|
-
|
(55,413
|
)
|
||||||||||||||||||
General and administrative
|
(48,940
|
)
|
(18,045
|
)
|
-
|
(30,895
|
)
|
(26,851
|
)
|
(5,592
|
)
|
-
|
(21,259
|
)
|
||||||||||||||||||
Total operating expenses
|
(173,730
|
)
|
(38,772
|
)
|
-
|
(134,958
|
)
|
(124,674
|
)
|
(13,828
|
)
|
-
|
(110,846
|
)
|
||||||||||||||||||
Income (loss) from operations
|
$
|
107,009
|
$
|
(40,792
|
)
|
$
|
-
|
$
|
147,801
|
$
|
72,465
|
$
|
(14,666
|
)
|
$
|
-
|
$
|
87,131
|
||||||||||||||
Unrealized gain (loss) on short-term investments
|
(1,151
|
)
|
-
|
(1,151
|
)
|
-
|
(4,428
|
)
|
-
|
(4,428
|
)
|
-
|
||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
72,547
|
$
|
(40,792
|
)
|
$
|
(1,151
|
)
|
$
|
114,490
|
$
|
59,649
|
$
|
(14,666
|
)
|
$
|
(4,428
|
)
|
$
|
78,743
|
||||||||||||
Basic EPS
|
$
|
1.17
|
$
|
1.85
|
$
|
0.99
|
$
|
1.31
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
1.07
|
$
|
1.70
|
$
|
0.90
|
$
|
1.19
|